Literature DB >> 1459696

Changes in serum glycoprotein glycosylation during experimental inflammation in mice are general, unrelated to protein type, and opposite changes in man and rat: studies on mouse serum alpha 1-acid glycoprotein, alpha 1-esterase, and alpha 1-protease inhibitor.

P M Heegaard1.   

Abstract

Using the method of crossed affinity immunoelectrophoresis with concanavalin A in combination with digital image processing, unrelated serum glycoproteins from normal mice and from mice undergoing an experimentally induced inflammation were analyzed for their carbohydrate-derived microheterogeneity profile. This profile changed in a generalized way in mouse serum samples taken at various time intervals after the initial induction of inflammation. The changes are not related to the acute-phase behavior of the protein itself (be it positive, negative, or nonreacting), and they are opposite to the changes in microheterogeneity profiles reported previously for glycoproteins during the acute phase in human and rat sera. These findings are discussed in the context of the biosynthetic control of glycoprotein glycosylation during the acute-phase response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459696     DOI: 10.1007/bf00919346

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  37 in total

1.  Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.

Authors:  W van Dijk; O Pos; M E van der Stelt; H J Moshage; S H Yap; L Dente; P Baumann; C B Eap
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

2.  Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.

Authors:  A Mackiewicz; D Schultz; J Mathison; M Ganapathi; I Kushner
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

Review 5.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Evidence for reduced uptake of asialo-alpha 1-acid glycoprotein during the acute phase response to inflammation.

Authors:  M W Wong; J C Jamieson
Journal:  Life Sci       Date:  1979-09-03       Impact factor: 5.037

7.  Alpha 1-protease inhibitor in serous effusions: differences in lectin crossed immuno-affinoelectrophoresis precipitin profiles between benign and malignant disease.

Authors:  A J Bleasby; J C Knowles; E H Cooper
Journal:  Int J Tissue React       Date:  1986

8.  Glycosylation of four acute-phase glycoproteins secreted by rat liver cells in vivo and in vitro. Effects of inflammation and dexamethasone.

Authors:  O Pos; W van Dijk; N Ladiges; C Linthorst; M Sala; D van Tiel; W Boers
Journal:  Eur J Cell Biol       Date:  1988-04       Impact factor: 4.492

9.  Studies of the effect of experimental inflammation on rat liver nucleotide sugar pools.

Authors:  H A Kaplan; B M Woloski; J C Jamieson
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1984

10.  Monokines regulate glycosylation of acute-phase proteins.

Authors:  A Mackiewicz; M K Ganapathi; D Schultz; I Kushner
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

2.  Glycan reductive isotope labeling for quantitative glycomics.

Authors:  Baoyun Xia; Christa L Feasley; Goverdhan P Sachdev; David F Smith; Richard D Cummings
Journal:  Anal Biochem       Date:  2009-02-10       Impact factor: 3.365

3.  Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity.

Authors:  Bettina Drescher; Torsten Witte; Reinhold E Schmidt
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.